SEARAINBOW(SZ:000503)2022-11-21 15:38Group 1: Company Overview - Guoxin Health is a publicly listed company with the stock code 000503 [1] - The company focuses on providing health insurance and related services [2] Group 2: Investor Relations Activities - The investor relations activity recorded on December 6, 2021, included a teleconference with various investment firms [3] - Key participants included representatives from Huatai Securities, Harvest Fund, and other investment institutions [2] Group 3: DRG/DIP Business Overview - The company has over 50 DRG (Diagnosis-Related Group) pilot projects and 20 DIP (Diagnosis-Intervention Payment) projects [3] - The main project forms include service methods, information technology construction, and a combination of both [3] - The most common charging method involves information technology construction plus service, varying by region [3] Group 4: Financial Aspects - The company aims for profitability or at least break-even in its DRG/DIP business, with local government funding generally covering project costs [4] - Initial setup costs for the DRG project in Jinhua were around 3-4 million, with annual operational costs stabilizing at approximately 2 million [4] - The annual service fee for the DRG project in Liuzhou is around 1 million [4] Group 5: Future Business Strategy - The company emphasizes the importance of providing professional systems and technical services as a key focus for future business development [4] - There is a recognition that competition in the hospital sector will drive improvements in products and services [5] - The company plans to leverage its established standards and local adaptations to maintain a competitive edge in the market [5]